Pricing Log in Create free account
Saturday 17 October 2026 Export LH’s income statement to Excel — free account

Labcorp Holdings Inc.

LH Healthcare Diagnostics & Research

Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024. In the quarter to June 2026, revenue grew 5.78%, EPS grew 28.4%, free cash flow fell 42.0% and total debt rose 15.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for three.

318.66 6.41 −1.97%
Market cap
$26.4B
P/E
26.2×
Fwd P/E
19.0×
Dividend yield
0.90%
F-score
8/9
Altman Z
3.02
Beneish M
−2.55
Dividend safety
74/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Labcorp Holdings Inc. (LH) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, Labcorp Holdings Inc. (LH) trades at a P/S ratio of 1.8×. Over the past ten years it has ranged from 0.8× (March 2020) to 2.0× (December 2021); the current reading is higher than 99% of that period. That is below the Diagnostics & Research industry median of 4.4× and below the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 1.5× 1.16%
FY2024 1.5× (11.20%)
FY2023 1.7× 6.18%
FY2022 1.6× (21.06%)
FY2021 2.0× 63.25%
FY2020 1.2× (1.15%)
FY2019 1.2× 26.78%
FY2018 1.0× (29.88%)
FY2017 1.4× 16.42%
FY2016 1.2× (1.60%)

Quarterly newest first

Period P/S ratio Change
Jun 2026 1.6× 2.70%
Mar 2026 1.6× 3.77%
Dec 2025 1.5× (13.67%)
Sep 2025 1.7× 6.73%
42 more quarters

Against its own ten years

Low 0.8× High 2.0×
Ten-year median 1.4×
Current reading's percentile 99

P/S ratio against peers

Company P/S ratio
LH Labcorp Holdings Inc. 1.8×
DGX Quest Diagnostics Incorporated compare 2.3×
RVTY Revvity Inc. compare 5.8×
MEDP Medpace Holdings, Inc. compare 6.3×
MTD Mettler-Toledo International, Inc. compare 7.9×
ILMN Illumina, Inc. compare 8.8×
WAT Waters Corporation compare 9.2×
IDXX IDEXX Laboratories, Inc. compare 9.7×
GH Guardant Health, Inc. compare 17.8×
Diagnostics & Research industry median 4.4×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on LH